More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

AGM presentation and business and trading update

Nov 29, 2022 at 9:41 PM EST · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Nov 29, 2022 at 9:41 PM EST · 33 pages · English

On 6ix: 6ix.com/news/agm-presentation-and-business-and-trading-update

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26↗

Mayne Pharma Group Ltd. on 6ix

In the deck

  • Mayne Pharma Group — Shareholder Meeting (November 2022)32 slidesNov 30, 2022

Story so far

  • 2021 Mayne Pharma AGM SpeechesNov 23, 2021

Earlier from Mayne Pharma

  • Return of Capital - MYXOct 27, 2022
  • Dividend/Distribution - MYXOct 27, 2022
  • Mayne Pharma capital management updateOct 27, 2022
  • Mayne Pharma completes sale of Metrics Contract ServicesOct 5, 2022
  • Mayne Pharma - appointment of chief executive officer and Managing DirectorSep 29, 2022

Later from Mayne Pharma

  • MYX signs license agreement for womens health productsDec 4, 2022
  • MYX completes TherapeuticsMD product licensing transactionJan 2, 2023
  • Mayne Pharma provides update on capital management timelineJan 11, 2023
  • Mayne Pharma and Mithra announce US launch of HALOETTE, a generic version of NUVARINGJan 16, 2023
  • Mayne Pharma to restate US dermatology net revenue for FY22Feb 14, 2023
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer